Facebook
Twitter
Telegram
Report an ErrorTrillium Therapeutics Inc. Financial Statements 2011-2024 | TRIL
Annual Financial Statements Trillium Therapeutics Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.1 B | 104 M | 24.3 M | 79.1 M | 36.8 M | 53.4 M | 58.4 M | 20.5 M | - | - |
Shares |
83.8 M | 25.3 M | 13.9 M | 9.77 M | 7.82 M | 6.64 M | 4.2 M | 1.36 M | - | - |
Net Income |
-59.3 M | -41.6 M | -32.9 M | -45.1 M | -31.7 M | -14.7 M | -12.9 M | -4.03 M | -1.07 M | -3.11 M |
Revenue |
148 K | 124 K | - | - | - | - | - | - | - | - |
EBITDA |
-60.9 M | -33.3 M | -33.9 M | -37.5 M | -30.5 M | -20.9 M | -12.5 M | -3.39 M | -1.09 M | -2.88 M |
Operating Expenses |
61.6 M | 32.6 M | 34.5 M | 32.6 M | 25.1 M | 15.3 M | 11.3 M | - | - | - |
General and Administrative Expenses |
36.3 M | 4.3 M | 3.85 M | 3.85 M | 3.57 M | 2.64 M | 2.34 M | 904 K | 469 K | 1.41 M |
All numbers in USD currency